| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.868 | 7.046 | 10.838 | 35.156 | 885 | 21.314 | 7.660 | 32.390 | 69.650 | 68.922 |
| Total Income - EUR | 5.868 | 7.046 | 10.838 | 35.156 | 890 | 21.314 | 7.664 | 32.390 | 69.650 | 68.922 |
| Total Expenses - EUR | 4.794 | 6.574 | 5.696 | 21.994 | 8.569 | 25.926 | 7.395 | 11.079 | 13.108 | 12.440 |
| Gross Profit/Loss - EUR | 1.074 | 472 | 5.142 | 13.162 | -7.679 | -4.612 | 268 | 21.310 | 56.542 | 56.482 |
| Net Profit/Loss - EUR | 898 | 282 | 4.817 | 12.810 | -7.688 | -4.825 | 38 | 20.987 | 55.846 | 55.449 |
| Employees | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Omicron Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 15.945 | 16.010 | 15.707 | 15.358 | 16.177 | 20.127 | 20.750 |
| Current Assets | 25.769 | 28.762 | 44.585 | 43.512 | 26.607 | 30.902 | 29.487 | 45.970 | 37.343 | 36.430 |
| Inventories | 16.341 | 16.174 | 23.387 | 17.237 | 17.627 | 12.742 | 21.772 | 21.840 | 21.773 | 21.652 |
| Receivables | 4.938 | 10.100 | 8.272 | 26.261 | 8.157 | 17.580 | 7.703 | 4.056 | 6.873 | 6.835 |
| Cash | 4.490 | 2.488 | 12.926 | 14 | 823 | 580 | 12 | 20.075 | 8.697 | 7.944 |
| Shareholders Funds | 21.572 | 21.634 | 26.084 | 38.416 | 29.986 | 24.592 | 24.085 | 45.147 | 55.896 | 55.499 |
| Social Capital | 45 | 45 | 44 | 43 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 4.197 | 7.128 | 18.500 | 21.041 | 12.632 | 22.016 | 20.760 | 17.001 | 1.574 | 1.681 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2825 - 2825" | |||||||||
| CAEN Financial Year |
7410
|
|||||||||
Comments - Omicron Plus Srl